People looking to boost their existing hair care routine with a powerful, internal treatment
The company has gathered a technical team of overseas returnees, university professors, industry experts and other fields such as enzyme engineering, fermentation engineering, molecular biology, AI technology, chemistry, materials science, pharmacy and engineering
Meet the Team
Stress, insomnia and mood imbalances often clinically present together and share common pathophysiological pathways
Moreover, last year a separate study showed that 91% of obese individuals receiving a weekly dose of 15 mg Tirzepatidea recently developed GLP-1R/GIPR dual agonist, lost 5% of their body mass with 36% of participants on the same dosage losing at least 25% ( While these data are astoundingwith yearly progress in efficacy, we should consider that around 9% of patients receiving these game-changer treatments (Table 1)
What the Research Gap Means in Practice Honesty demands acknowledging the obvious: the human clinical data on stacking BPC-157 with GLP-1 agonists is essentially nonexistent
